首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1280768

美國淋巴水腫治療市場預測至2028年 - 按病情類型、治療類型和終端用戶的COVID-19影響和國家分析

US Lymphedema Treatment Market Forecast to 2028 - Country Analysis By Condition Type, Treatment Type, and End User

出版日期: 2023年05月12日 | 出版商:

The Insight Partners | 英文 132 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

美國淋巴水腫治療市場規模預計將從2022年的51.8598億美元成長到2028年的83.207億美元；估計從2023年到2028年將錄得8.2%的複合成長率。

美國淋巴水腫治療市場的成長歸功於淋巴水腫病例發病率的上升，以及醫療保健服務和淋巴水腫管理項目的增加。然而，缺乏意識和熟練的專業人員阻礙了市場的成長。

淋巴水腫是指淋巴液在皮膚下面的脂肪組織中的積聚。這種情況是由於一個人的淋巴系統流動受阻造成的，可以在腿部或手臂或兩者中觀察到。它也可能影響一個人的腹部、頸部、生殖器和麵部，這取決於接受治療的身體部位。原發性淋巴水腫一般在出生時就存在，而繼發性淋巴水腫是由於淋巴系統功能失調或損壞造成的。

根據美國心臟病學院基金會的報告，淋巴水腫的治療主要由症狀管理、減少體積和預防感染來推動。例如，淋巴水腫的第一線治療是保守治療。完全減容療法（CGT）已成為物理治療性保守管理的前沿陣地。此外，外科治療方法為保守治療提供了良好的依從性。此外，用於治療淋巴水腫的新的微創血管化淋巴結轉移術已在世界範圍內獲得了極大的關注。例如，位於亞利桑那州鳳凰城/斯科茨代爾的梅奧診所園區的醫生們已經開發出一種新的門診手術，用於治療對傳統療法不適用的淋巴水腫患者。與淋巴結轉移相關的好處是大大減少了疼痛和淋巴解剖的腫脹。此外，該手術允許患者減少抗生素的使用，在患者群體中增加了生活品質的好處。此外，被診斷為乳腺癌、皮膚陰莖癌、膀胱癌和婦科癌症的患者可以接受淋巴結手術。

淋巴水腫是一種慢性的、無法治癒的疾病，影響著病人的身體和精神健康。事實證明，基於期限的護理是一種多學科的病人管理方法。定期護理團隊包括來自物理康復、血管醫學、整形外科、放射科、腫瘤科、傳染病和社會工作的人員。該團隊可以為評估肢體腫脹的病因提供全面的評估，最佳化保守護理，並為合適的人選提供手術治療。

MedStar Health報告指出，患者的淋巴水腫治療計劃將取決於病因和病情的嚴重程度。醫生可能會開藥或轉診給專門管理淋巴水腫的物理或職業治療師。療法包括通過鍛煉、特殊按摩技術或機械泵裝置來減少腫脹和控制疼痛。如果病人的病情嚴重，醫生可能會建議進行更先進的治療，如淋巴結轉移和淋巴管分流。

梅奧醫學教育和研究基金會的報告指出，與以前使用的腹腔鏡手術相比，機器人技術在淋巴手術中的效用使其具有更大的靈活性和精確性。此外，事實證明，使用機器人技術對外科醫生和病人的效果都是最佳的，並將在預測期內顯示出積極的結果。例如，2020年5月接受單機器人手術治療淋巴水腫的患者提供了積極的傳聞反饋，包括顯著的臨床改善，如能夠穿上衣服，有了外科醫生的重大成就。此外，啟用人工智慧（AI）的機器人正擴大協助淋巴水腫手術中的顯微外科手術，以減少可能影響患者恢復的外科醫生變化。例如，對於淋巴水腫手術，2020年5月，一名泌尿外科醫生通過利用自由淋巴結轉移，進行了首例單孔機器人精神收割，旨在對淋巴水腫進行微創手術治療。這種新的手術治療方法的主要目的是最大限度地減少供體部位的發病率與衰弱的淋巴水腫症狀。

基於治療的見解

根據治療方法，美國淋巴水腫治療市場被分為雷射治療、壓縮設備和繃帶、藥物治療、生理程序、切除程序及其他。生理程序部分被進一步細分為淋巴管吻合術（LVA）和血管化淋巴結轉移術（VLNT）。同樣，切除程序部分又被細分為手術切除、吸脂和其他。 2022年，壓縮設備和繃帶部分佔據了市場的最大佔有率。在預測期內，生理程序部分預計將錄得最高的複合年成長率，主要是由於通過對淋巴水腫患者進行的LVA和VLNT治療的可用性。目前有兩種主要的生理干預措施被涵蓋治療淋巴水腫。主要的干預措施是在靠近淋巴阻塞的位置，在充血的淋巴通道與靜脈系統之間建立一個分流（一個孔或一個小通道，以方便移動）。另一種生理干預措施是結合血管化軟組織瓣，其中經常包括受影響的淋巴結的血管化淋巴結。在這部分中，血管化淋巴結轉移（VLNT）手術在預測年內將以最高的年復合成長率%成長。北美放射學會（RSNA）指出，淋巴水腫的治療在傳統上是保守的和有限的，但如今手術和顯微外科手術已經大大增加了。例如，VLNT是微型手術中最突出和最有前途的技術之一。 VLNT涉及將功能淋巴結（LNs）從健康的供體部位轉移到身體中淋巴引流受損或病變的區域。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳大利亞
- 亞太其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美和中美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第十一章：COVID-19大流行對臨床試驗成像市場的影響

北美洲：對COVID-19大流行的評估
歐洲
亞太地區
南美洲和中美洲
中東和非洲

第十二章：臨床試驗成像市場- 行業格局

概述
臨床試驗成像市場的成長策略
無機成長戰略
- 概述
有機成長策略
- 綜述

第十三章：公司簡介

eResearch Technology Inc
Calyx Inc
ICON PLC
VIDA Diagnostics Inc
WCG Clinical Inc
BioTelemetry Inc
Medical Metrics Inc
Medpace Holdings Inc
Radiant Sage LLC
IXICO plc

第十四章：附錄

關於洞察力合作夥伴
術語表

簡介目錄圖表

Product Code: TIPRE00029907

The US lymphedema treatment market size is expected to grow from US$ 5,185.98 million in 2022 to US$ 8,320.07 million by 2028; it is estimated to record a CAGR of 8.2% from 2023 to 2028.

The US lymphedema treatment market growth is attributed to the rising incidence of lymphedema cases and increasing healthcare services and lymphedema management programs. However, a lack of awareness and skilled proffesionals is hampering the growth of the market.

Lymphedema involve the accumulation of lymph fluid in fatty tissues just beneath the skin. The condition is caused due to impaired flow in the lymphatic system of a person and is observed either in the legs or arms or in both. It can also be affecting abdomen, neck, genitals, and face of a person, depending on the portion of the body which has undergone treatment. Primary lymphedema is generally present at birth, while secondary lymphedema is caused due to dysfunction or damage to the lymphatic system.

According to the American College of Cardiology Foundation report, the treatment of lymphedema is primarily driven by symptom management, volume reduction, and infection prevention. For example, the first line of treatment for lymphedema is conservative management. Complete decongestive therapy (CGT) has become the forefront of physiotherapeutic conservative management. Additionally, surgical treatment approaches provide good adherence to conservative management. Moreover, the new minimally invasive vascularized lymph node transfer for lymphedema has gained significant attention worldwide. For example, physicians at Mayo Clinic's campus in Phoenix/Scottsdale, Arizona, have developed a new outpatient surgical procedure for patients experiencing lymphedema refractory to traditional therapy. Benefits associated with lymph node transfer involve a significant reduction of pain and swelling in the lymphedemic anatomy. Also, the surgery allows patients to decrease their antibiotic use, adding quality-of-life benefits among the patient pool. Further, patients diagnosed with breast, skin penile, bladder, and gynecological cancers may undergo lymph nodes procedure.

Lymphedema is a chronic, incurable disease affecting a patient's physical and mental well-being. Term-based care proves to be a multidisciplinary approach for patient management. The term-based care team includes people from physical rehabilitation, vascular medicine, plastic surgery, radiology, oncology, infectious disease, and social work. The team can provide a thorough evaluation for assessing the etiology of limb swelling, optimizing conservative care, and offering surgical treatment for appropriate candidates.

MedStar Health report states that a patient's lymphedema treatment plans will depend on the cause and severity of the condition. Doctors may prescribe medication or refer to a physical or occupational therapist specializing in the management of lymphedema. Therapies include reducing swelling and controlling pain through exercises, special massage techniques, or mechanical pumping devices. If a patient's condition is severe, doctors may recommend more advanced treatments such as lymph node transfer and lymphovenous bypass.

The Mayo Foundation for Medical Education and Research report states that the utility of robotics for lymphatic surgery allows much greater flexibility and precision compared to previously used laparoscopy. Additionally, the use of robotics proves optimal for both surgeon and patient outcomes and will reveal positive results during the forecast period. For instance, patients who underwent single-robotic surgery for lymphedema in May 2020 have provided positive anecdotal feedback, including significant clinical improvement such as the ability to wear clothes with the surgeon's significant accomplishments. Further, robots enabled with artificial intelligence (AI) are increasingly assisting in microsurgical procedures in lymphedema surgeries for reducing surgeon variations that could affect patient recovery. For example, for lymphedema surgery, in May 2020, an urogynecology surgeon performed a first-of-its-kind single-port robotic mental harvest by utilizing a free lymph node transfer, intended for minimally invasive surgical treatment of lymphedema. The main objective of this new surgical treatment method is to minimize donor site morbidity with debilitating lymphedema symptoms.

Treatment-Based Insights

Based on treatment, the US lymphedema treatment market is categorized into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others. The physiological procedures segment is further segmented into lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT). Similarly, the debulking procedures segment is subdivided into surgical debulking, liposuction, and others. The compression devices and bandaging segment held the largest share of the market in 2022. The physiological procedure segment is anticipated to register the highest CAGR during the forecast period mainly due to the treatment availability through LVA and VLNT performed on lymphedema patients. Two main physiologic interventions are currently incorporated to treat lymphedema. The primary intervention creates a shunt (a hole or a small passage to facilitate movement) between the congested lymphatic channels with the venous system close to the location of lymphatic obstruction. The other physiologic intervention incorporates vascularized soft tissue flaps that frequently include vascularized lymph nodes to the affected lymphatic extremity. Under this segment, the vascularized lymph node transfer (VLNT) procedure will grow at the highest CAGR% during the forecasted year. The Radiological Society of North America (RSNA) states that lymphedema treatment has traditionally been conservative and limited, but surgical and microsurgical procedures have risen tremendously today. For instance, VLNT is one of the most prominent and promising techniques for micro surgeries. VLNT involves the transfer of functional lymph nodes (LNs) from a healthy donor site to an area of the body with damaged or diseased lymphatic drainage.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US lymphedema treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the US lymphedema treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

2. US Lymphedema Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage 24
3.2 Secondary Research
3.3 Primary Research

4. Lymphedema Treatment Market – Market Landscape

4.1 Overview
4.2 Experts' Opinion

5. Lymphedema Treatment Market – Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Incidence of Lymphedema Cases
- 5.1.2 Increasing Healthcare Services and Lymphedema Management Programs
5.2 Market Restraints
- 5.2.1 Lack of Awareness and Skilled Professionals
5.3 Market Opportunities
- 5.3.1 Rising Treatment Options
5.4 Future Trends
- 5.4.1 Use of Robotics for Lymphedema Treatment
5.5 Impact Analysis

6. US Lymphedema Treatment Market Analysis

6.1 US Lymphedema Treatment Market Revenue Forecast and Analysis
6.2 US Lymphedema Treatment Market, By Company Products

7. US Lymphedema Treatment Market Analysis – by Condition Type

7.1 Overview
7.2 Primary Lymphedema
7.3 Secondary Lymphedema

8. US Lymphedema Treatment Market Analysis – by Treatment Type

8.1 Overview
8.2 Laser Therapy
8.3 Compression Devices and Bandaging
8.4 Drug Therapy
8.5 Physiological Procedures
8.6 Debulking Procedures
8.7 Others

9. US Lymphedema Treatment Market Analysis – by End User

9.1 Overview
9.2 Hospitals
9.3 Clinics
9.4 Clinical Research Organization
9.5 Others

10. US Lymphedema Treatment Market

10.1 Overview
- 10.1.1 US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.1 US Lymphedema Treatment Market, by Condition Type, 2019–2028 (USD Million)
  - 10.1.1.2 US Lymphedema Treatment Market, by Treatment Type, 2019–2028 (USD Million)
  - 10.1.1.3 US Lymphedema Treatment Market, by End User, 2019–2028 (USD Million)

11. US Lymphedema Treatment Market: Impact Assessment of COVID-19 Pandemic

11.1 Impact Analysis of COVID-19 Pandemic on US Lymphedema Treatment Market

12. US Lymphedema Treatment Market–Industry Landscape

12.1 Overview
12.2 Organic Developments

13. Company Profiles

13.1 BIOCOMPRESSION SYSTEMS
13.2 Tactile Medical
13.3 Essity AB
13.4 Lohmann & Rauscher GmbH & Co. KG
13.5 SIGVARIS GROUP
13.6 ThermoTek Inc
13.7 Huntleigh Healthcare Limited
13.8 3M Co
13.9 AIROS Medical
13.10 PAUL HARTMANN AG

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. UK Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 20. UK Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 21. UK Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. France: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 23. France: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 24. France: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 37. China Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 38. China Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 39. China Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 43. India Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 44. India Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 45. India Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 55. South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 56. South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 57. South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 58. Brazil Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 59. Brazil Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 60. Brazil Clinical Trial Imaging Market, by End Use- Revenue and Forecast to 2028 (US$ Million)
Table 61. Argentina Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 62. Argentina Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 63. Argentina Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 67. Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 68. Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 69. Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 70. South Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 71. South Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 72. South Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 73. Saudi Arabia Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 74. Saudi Arabia Clinical Trial Imaging Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 75. Saudi Arabia Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 76. UAE Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 77. UAE Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 78. UAE Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 82. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
Table 83. Recent Organic Growth Strategies in Clinical Trial Imaging Market
Table 84. Glossary of Terms

List Of Figures

Figure 1. Clinical Trial Imaging Market Segmentation
Figure 2. Clinical Trial Imaging Market by Region
Figure 3. Global Clinical Trial Imaging Market Overview
Figure 4. Tomography Largest Share of Modality Segment in Clinical Trial Imaging Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Clinical Trial Imaging Market, by Geography (US$ Million)
Figure 7. Global Clinical Trial Imaging Market - Leading Country Markets (US$ Million)
Figure 8. Global Clinical Trial Imaging Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Clinical Trial Imaging Market - Revenue Forecast and Analysis - 2021-2028
Figure 16. Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis (2022-2028)
Figure 17. Market Positioning of Key Players in the Clinical Trial Imaging Market
Figure 18. Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
Figure 19. Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
Figure 27. Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
Figure 33. Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 38. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
Figure 40. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Europe: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 44. Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
Figure 46. Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia Pacific: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 53. Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 54. China Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 55. Japan Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 56. India Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 57. South Korea Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 58. Australia Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. South and Central America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 61. South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. Brazil Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. Argentina Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
Figure 65. Middle East & Africa: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 66. Middle East & Africa Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 71. Impact of COVID-19 Pandemic on North American Country Markets
Figure 72. Impact of COVID-19 Pandemic on European Country Markets
Figure 73. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 74. Impact of COVID-19 Pandemic on South and Central America Country Markets
Figure 75. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
Figure 76. Growth Strategies in Clinical Trial Imaging Market